Cart
sales@molnova.com
TCS 1102
CAS No. 916141-36-1
TCS 1102 ( TCS 1102, TCS1102, TCS-1102 )
Catalog No. M17659 CAS No. 916141-36-1
TCS 1102 is an effective, dual orexin receptor antagonist (Ki: 0.2/3 nM for OX2/1 receptors).
Purity : 97%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 51 | In Stock |
|
| 10MG | 81 | In Stock |
|
| 25MG | 158 | In Stock |
|
| 50MG | 291 | In Stock |
|
| 100MG | 408 | In Stock |
|
| 500MG | 945 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTCS 1102
-
NoteResearch use only, not for human use.
-
Brief DescriptionTCS 1102 is an effective, dual orexin receptor antagonist (Ki: 0.2/3 nM for OX2/1 receptors).
-
DescriptionTCS 1102 is a potent, dual orexin receptor antagonist (Ki values are 0.2 and 3 nM for OX2 and OX1 receptors respectively). TCS 1102 inhibits ADL-orexin B-mediated locomotion following i.p. administration in vivo and blocks orexin-A (Cat.No.1455) mediated increases in feeding behaviour.
-
SynonymsTCS 1102, TCS1102, TCS-1102
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorOX1; OX2
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number916141-36-1
-
Formula Weight470.59
-
Molecular FormulaC27H26N4O2S
-
Purity97%
-
SolubilityDMSO : ≥ 100 mg/mL; 212.50 mM
-
SMILESCn1c2ccccc2nc1SCC(=O)N1CCC[C@H]1C(=O)Nc1ccccc1c1ccccc1
-
Chemical Name(2S)-1-[2-(1-methylbenzimidazol-2-yl)sulfanylacetyl]-N-(2-phenylphenyl)pyrrolidine-2-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bergman JM, et al. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1425-30.
molnova catalog
related products
-
Cdc7 inhibitor 7c
A highly potent, selective and time-dependent Cdc7 kinase inhibitor with IC50 of 0.7 nM with slow dissociation property, with 200-fold and >14,000-fold selectivity over CDK2 and ROCK1, respectively.
-
Ro-3306
Ro-3306 is a potent, selective, ATP-competitive CDK1 inhibitor with Ki of 35 nM against CDK1/cyclin B1, 10-fold selectivity relative to CDK2/cyclin E and >50-fold relative to CDK4/cyclin D.
-
LY2857785
LY2857785 is a potenrt, reversible and ATP-competitive CDK9 inhibitor with IC50 of 11 nM, also inhibits CDK8 (IC50=16 nM) and weakly inhibits CSK7 (IC50=246 nM).
